Mast cell tumors

Withrow & MacEwen's Small Animal Clinical Oncology

Volumn , Issue , 2007, Pages 402-424

  Thamm, Douglas H ^a   Vail, David M ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882884013     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072160558-6.50022-8     Document Type: Chapter

References (147)

1. Bostock DE Neoplasms of the skin and subcutaneous tissues in dogs and cats. Br Vet J 1986, 142:1-19.
2. Carpenter JL, Andrews LK, Holzworth J Tumors and tumor-like lesions. Diseases of the cat: medicine and surgery 1987, WB Saunders, Philadelphia. J. Holzworth (Ed.).
3. Finnie JW, Bostock DE Skin neoplasia in dogs. Aust Vet J 1979, 55:602-604.
4. Miller MA, Nelson SL, Turk JR, et al. Cutaneous neoplasia in 340 cats. Vet Pathol 1991, 28:389-395.
5. Rothwell TLW, Howlett CR, Middleton DJ, et al. Skin neoplasms of dogs in Sydney. Aust Vet J 1987, 64:161-164.
6. Brodey RS Canine and feline neoplasia. Adv Vet Sci Comp Med 1970, 14:309-354.
7. Davis BJ, Page R, Sannes PL, et al. Cutaneous mastocytosis in a dog. Vet Pathol 1992, 29:363-365.
8. Patnaik AK, Ehler WJ, MacEwen EG Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984, 21:469-474.
9. Peters JA Canine mastocytoma: excess risk as related to ancestry. J Natl Cancer Inst 1969, 42:435-443.
10. Dunn TB, Patter H A transplantable mast cell neoplasm in the mouse. J Natl Cancer Inst 1957, 18:587-601.
11. Hottendorf GH, Neilson SW Survey of 300 extirpated canine mastocytomas. Zentralbl Veterinarmed A 1967, 14:272-281.
12. Peterson SL Scar-associated canine mast cell tumor. Canine Pract 1985, 12:23-29.
13. Bowles CA, Kerber WT, Rangan SRS, et al. Characterization of a transplantable canine immature mast cell tumor. Cancer Res 1972, 32:1434-1441.
14. Lombard LS, Moloney JB Experimental transmission of mast cell sarcoma in dogs. Fed Proc 1959, 18:490-495.
15. Nielson SW, Cole CR Homologous transplantation of canine neoplasms. Am J Vet Res 1961, 27:663-672.
16. Stone JM, Jacky PB, Prieur DJ Chromosomal fragile site expression in boxer dogs with mast cell tumors. Am J Med Genet 1991, 40:223-229.
17. Ginn PE, Fox LE, Brower JC, et al. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Vet Pathol 2000, 37:33-39.
18. Jaffe MH, Hosgood G, Taylor HW, et al. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Vet Pathol 2000, 37:40-46.
19. Ozaki K, Yamagami T, Nomura K, et al. Mast cell tumors of the gastrointestinal tract in 39 dogs. Vet Pathol 2002, 39:557-564.
20. Mayr B, Reifinger M, Brem G, et al. Cytogenetics, ras, and p53: studies in cases of canine neoplasms (hemangiopericytoma, mastocytoma, histiocytoma, chloroma). J Hered 1999, 90:124-128.
21. Wu H, Hayashi T, Inoue M Immunohistochemical expression of p27 and p21 in canine cutaneous mast cell tumors and histiocytomas. Vet Pathol 2004, 41:296-299.
22. Kiupel M, Webster JD, Kaneene JB, et al. The use of Kit and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 2004, 41:371-377.
23. London CA, Kisseberth WC, Galli SJ, et al. Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumors. J Comp Pathol 1996, 115:399-414.
24. Morini M, Bettini G, Preziosi R, et al. C-Kit gene product (CD117) immunoreactivity in canine and feline paraffin sections. J Histochem Cytochem 2004, 52:705-708.
25. Reguera MJ, Rabanal RM, Puigdemont A, et al. Canine mast cell tumors express stem cell factor receptor. Am J Dermatopathol 2000, 22:49-54.
26. Costa JJ, Demetri GD, Harrist TJ, et al. Recombinant human stem cell factor (Kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996, 183:2681-2686.
27. Jones CL, Grahn RA, Chien MB, et al. Detection of c-Kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis. J Vet Diagn Invest 2004, 16:95-100.
28. Zemke D, Yamini B, Yuzbasiyan-Gurkan V Mutations in the juxtamembrane domain of c-Kit are associated with higher grade mast cell tumors in dogs. Vet Pathol 2002, 39:529-535.
29. Reguera MJ, Ferrer L, Rabanal RM Evaluation of an intron deletion in the c-Kit gene of canine mast cell tumors. Am J Vet Res 2002, 63:1257-1261.
30. Downing S, Chien MB, Kass PH, et al. Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-Kit in mast cell tumors of dogs. Am J Vet Res 2002, 63:1718-1723.
31. Dank G, Chien MB, London CA Activating mutations in the catalytic or juxtamembrane domain of c-Kit in splenic mast cell tumors of cats. Am J Vet Res 2002, 63:1129-1133.
32. Elling H, Ungemach FR Sexual hormone receptors in canine mast cell tumour cytosol. J Comp Pathol 1982, 92:629-630.
33. Macy DW Canine and feline mast cell tumors: biologic behavior, diagnosis, and therapy. Semin Vet Med Surg (Small Anim) 1986, 1:72-83.
34. Gerritsen RJ, Teske E, Kraus JS, et al. Multiagent chemotherapy for mast cell tumours in the dog. Vet Q 1998, 20:28-31.
35. Hottendorf GH, Nielsen SW Pathologic report of 29 necropsies on dogs with mastocytoma. Vet Pathol 1968, 5:102-121.
36. Cahalane AK, Payne S, Barber LG, et al. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002). J Am Vet Med Assoc 2004, 225:401-408.
37. Michels GM, Knapp DW, DeNicola DB, et al. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus non-tumor-free margins: a retrospective study of 31 cases. J Am Anim Hosp Assoc 2002, 38:458-466.
38. Mullins MN, Dernell WS, Withrow SJ, et al. The syndrome of multiple cutaneous canine mast cell tumors: 54 cases (1998-2004). J Am Vet Med Assoc 2006, 228:91-95.
39. Murphy S, Sparkes AH, Smith KC, et al. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Vet Rec 2004, 154:743-746.
40. Seguin B, Leibman NF, Bregazzi VS, et al. Clinical outcome of dogs with grade II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 2001, 218:1120-1123.
41. Weisse C, Shofer FS, Sorenmo K Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 2002, 38:71-73.
42. Bostock DE The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973, 14:27-40.
43. O'Keefe DA, Couto CG, Burke-Schwartz C, et al. Systemic mastocytosis in 16 dogs. J Vet Intern Med 1987, 1:75-80.
44. Fox LE, Rosenthal RC, Twedt DC, et al. Plasma histamine and gastrin concentrations in 17 dogs with mast cell tumors. J Vet Intern Med 1990, 4:242-246.
45. Howard EB, Sawa TR, Nielson SW, et al. Mastocytoma and gastroduodenal ulceration. Vet Pathol 1969, 6:146-158.
46. Ishiguro T, Kadosawa T, Takagi S, et al. Relationship of disease progression and plasma histamine concentrations in 11 dogs with mast cell tumors. J Vet Intern Med 2003, 17:194-198.
47. Roberts LJ, Sweetman BJ, Lewis RA, et al. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 1980, 303:1400-1484.
48. Scott HW, Parris WCV, Sandidge PC, et al. Hazards in operative management of patients with systemic mastocytosis. Ann Surg 1983, 197:507-514.
49. Hottendorf GH, Nielsen SW, Kenyon AJ Canine mastocytoma. I. Blood coagulation time in dogs with mastocytoma. Pathol Vet 1965, 2:129-141.
50. Kenyon AJ, Ramos L, Michaels EB Histamine-induced suppressor macrophage inhibits fibroblast growth and wound healing. Am J Vet Res 1983, 44:2164-2166.
51. Huttunen M, Hyttinen M, Nilsson G, et al. Inhibition of keratinocyte growth in cell culture and whole skin culture by mast cell mediators. Exp Dermatol 2001, 10:184-192.
52. Tams TR, Macy DW Canine mast cell tumors. Comp Cont Ed Pract Vet 1981, 27:259-263.
53. Van Pelt DR, Fowler JD, Leighton FA Multiple cutaneous mast cell tumors in a dog: a case report and brief review. Can Vet J 1986, 27:259-263.
54. Iwata N, Ochiai K, Kadosawa T, et al. Canine extracutaneous mast-cell tumours consisting of connective tissue mast cells. J Comp Pathol 2000, 123:306-310.
55. Moore LE, Garrett LD, Debey B, et al. Spinal mast cell tumor in a dog. J Am Anim Hosp Assoc 2002, 38:67-70.
56. Steffey M, Rassnick KM, Porter B, Njaa BL Ureteral mast cell tumor in a dog. J Am Anim Hosp Assoc 2004, 40:82-85.
57. Davies AP, Hayden DW, Klausner JS, et al. Noncutaneous systemic mastocytosis and mast cell leukemia in a dog: case report and literature review. J Am Anim Hosp Assoc 1981, 17:361-368.
58. Lester SL, McGonigle LF, McDonald GK Disseminated anaplastic mastocytoma with terminal mastcythemia in a dog. J Am Anim Hosp Assoc 1981, 17:355-360.
59. Takahashi T, Kadosawa T, Nagase M, et al. Visceral mast cell tumors in dogs: 10 cases (1982-1997). J Am Vet Med Assoc 2000, 216:222-226.
60. Pollack MJ, Flanders JA, Johnson RC Disseminated malignant mastocytoma in a dog. J Am Anim Hosp Assoc 1991, 27:435-440.
61. Thamm DH, Turek MM, Vail DM Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumor: 61 cases. J Vet Med Sci 2006, 68:581-587.
62. Bostock DE, Crocker D, Harris K, et al. Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours. Br J Cancer 1989, 59:915-918.
63. Simoes JPC, Schoning P, Butine M Prognosis of canine mast cell tumors: a comparison of three methods. Vet Pathol 1994, 31:637-647.
64. Kravis LG, Vail DM, Kisseberth WC, et al. Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens from mast cell tumors in dogs. J Am Vet Med Assoc 1996, 209:1418-1420.
65. Preziosi R, Sarli G, Paltrinieri M Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog. J Comp Pathol 2004, 130:143-151.
66. Abadie JJ, Amardeilh MA, Delverdier ME Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 1999, 215:1629-1634.
67. Ayl RD, Couto CG, Hammer AS, et al. Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors. Vet Pathol 1992, 29:386-390.
68. Moriello KA, Rosenthal RC Clinical approach to tumors of the skin and subcutaneous tissues. Vet Clin N Am Small Anim Pract 1990, 20:1163-1190.
69. O'Keefe DA Canine mast cell tumors. Vet Clin N Am Small Anim Pract 1990, 20:1105-1115.
70. Richardson RC, Rebar AH, Elliott GS Common skin tumors of the dog: a clinical approach to diagnosis and treatment. Comp Cont Ed Pract Vet 1984, 6:1080-1086.
71. Turrel JM, Kitchell BE, Miller LM, et al. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 1988, 193:936-940.
72. Sfiligoi G, Rassnick KM, Scarlett JM, et al. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001). J Am Vet Med Assoc 2005, 226:1368-1374.
73. Thamm DH, Mauldin EA, Vail DM Prednisone and vinblastine chemotherapy for canine mast cell tumor: 41 cases (1992-1998). J Vet Intern Med 1999, 13:491-497.
74. Clinkenbeard KD Diagnostic cytology: mast cell tumors. Comp Cont Ed Pract Vet 1991, 13:1697-1704.
75. Plier ML, MacWilliams PS Systemic mastocytosis and mast cell leukemia. Schalm's veterinary hematology 2000, Lippincott Williams & Wilkins, Philadelphia. ed 5. B.F. Feldman, J.G. Zinkl, N.C. Jain (Eds.).
76. Hikasa Y, Morita T, Futaoka Y, et al. Connective tissue-type mast cell leukemia in a dog. J Vet Med Sci 2000, 62:187-190.
77. Bookbinder PF, Butt MT, Harvey HJ Determination of the number of mast cells in lymph node, bone marrow, and buffy coat cytologic specimens from dogs. J Am Vet Med Assoc 1992, 200:1648-1650.
78. Cayatte SM, McManus PM, Miller WH, et al. Identification of mast cells in buffy coat preparations from dogs with inflammatory skin diseases. J Am Vet Med Assoc 1995, 206:325-326.
79. McManus PM Frequency and severity of mastocytemia in dogs with and without mast cell tumors: 120 cases (1995-1997). J Am Vet Med Assoc 1999, 215:355-357.
80. Stockham SL, Basel DL, Schmidt DA: Mastocytemia in dogs with acute inflammatory diseases, Vet Clin Pathol .
81. Hahn KA, Lantz GC, Salisbury SK Comparison of survey radiography with ultrasonography and x-ray computed tomography for clinical staging of subcutaneous neoplasms in dogs. J Am Vet Med Assoc 1990, 196:1795-1798.
82. Simpson AM, Ludwig LL, Newman SJ, et al. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 2004, 224:236-240.
83. Allan GS, Gilette EL Response of canine mast cell tumors to radiation. J Natl Cancer Inst 1979, 63:691-694.
84. Gillette EL Indications and selection of patients for radiation therapy. Vet Clin N Am Small Anim Pract 1974, 4:889-896.
85. Gillette EL Radiation therapy of canine and feline tumors. J Am Anim Hosp Assoc 1976, 12:359-362.
86. Gillette EL Veterinary radiotherapy. J Am Vet Med Assoc 1976, 157:1707-1712.
87. McClelland RB The treatment of mastocytomas in dogs. Cornell Vet 1964, 54:517-519.
88. Al-Sarraf R, Mauldin GN, Patnaik AK, et al. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med 1996, 10:376-378.
89. Frimberger AE, Moore AS, LaRue SM, et al. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993), J. Am Anim Hosp Assoc 1997, 33:320-324.
90. LaDue T, Price GS, Dodge R, et al. Radiation therapy for incompletely resected canine mast cell tumors. Vet Radiol Ultrasound 1998, 39:57-62.
91. Chaffin K, Thrall DE Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis. Vet Radiol Ultrasound 2002, 43:392-395.
92. Hahn KA, King GK, Carreras JK Efficacy of radiation therapy for incompletely resected grade III mast cell tumors in dogs: 31 cases (1987-1998). J Am Vet Med Assoc 2004, 224:79-82.
93. Poirier VJ, Adams WM, Forrest LJ et al: Efficacy of radiation therapy for incompletely excised grade II mast cell tumors with or without lymph node prophylactic irradiation, Vet Rec, submitted, 2005.
94. Misdorp W Incomplete surgery, local immunostimulation, and recurrence of some tumour types in dogs and cats. Vet Q 1987, 9:279-286.
95. Lagoretta RA, Denman DL, Kelley MC, et al. Use of hyperthermia and radiotherapy in treatment of a large mast cell sarcoma in a dog. J Am Vet Med Assoc 1988, 193:1545-1548.
96. Theon AP, Madewell BR, Castro J: High dose-rate remote afterloading brachytherapy: preliminary results in canine and feline cutaneous and subcutaneous tumors, Proc Annu Conf Vet Cancer Soc:109-110, 1993.
97. Northrup NC, Roberts RE, Harrell TW, et al. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors. J Am Anim Hosp Assoc 2004, 40:309-315.
98. Frimberger AE, Moore AS, Cincotta L, et al. Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer. Clin Cancer Res 1998, 4:2207-2218.
99. Tanabe S, Yamaguchi M, Iijima M, et al. Fluorescence detection of a new photosensitizer, PAD-S31, in tumour tissues and its use as a photodynamic treatment for skin tumours in dogs and a cat: a preliminary report. Vet J 2004, 167:286-293.
100. Rogers KS Common questions about diagnosing and treating canine mast cell tumors. Vet Med 1993, 88:246-250.
101. Neyens IJ, Kirpensteijn J, Grinwis GC, et al. Pilot study of intraregional deionised water adjunct therapy for mast cell tumours in dogs. Vet Rec 2004, 154:90-91.
102. Grier RL, DiGuardo G, Schaffer CB, et al. Mast cell tumor destruction by deionized water. Am J Vet Res 1990, 51:1116-1120.
103. Grier RL, DiGuardo G, Myers R, et al. Mast cell tumour destruction in dogs by hypotonic solution. J Small Anim Pract 1995, 36:385-388.
104. Jaffe MH, Hosgood G, Kerwin SC, et al. The use of deionized water for the treatment of canine cutaneous mast cell tumors. Vet Cancer Soc Newsl 1998, 22:9-10.
105. Jaffe MH, Hosgood G, Kerwin SC, et al. Deionised water as an adjunct to surgery for the treatment of canine cutaneous mast cell tumours. J Small Anim Pract 2000, 41:7-11.
106. Asboe-Hanson G The mast cell: cortisone action on connective tissue. Proc Soc Exp Biol Med 1952, 80:677-679.
107. Bloom F Effect of cortisone on mast cell tumors (mastocytoma) of the dog. Proc Soc Exp Biol Med 1952, 80:651-654.
108. Brodey RS, McGrath JT, Martin JE Preliminary observations on the use of cortisone in canine mast cell sarcoma. J Am Vet Med Assoc 1953, 123:391-393.
109. Takahashi T, Kadosawa T, Nagase M, et al. Inhibitory effects of glucocorticoids on proliferation of canine mast cell tumor. J Vet Med Sci 1997, 59:995-1001.
110. McCaw DL, Miller MA, Ogilvie GK, et al. Response of canine mast cell tumors to treatment with oral prednisone. J Vet Intern Med 1994, 8:406-408.
111. Elmslie R Combination chemotherapy with and without surgery for dogs with high grade mast cell tumors with regional lymph node metastases. Vet Cancer Soc Newsl 1997, 20:6-7.
112. McCaw DL, Miller MA, Bergman PJ, et al. Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med 1997, 11:375-378.
113. Rassnick KM, Moore AS, Williams LE, et al. Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 1999, 13:601-605.
114. Davies DR, Wyatt KM, Jardine JE, et al. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. J Am Anim Hosp Assoc 2004, 40:124-130.
115. Zavodovskaya R, Chien MB, London CA Use of Kit internal tandem duplications to establish mast cell tumor clonality in 2 dogs. J Vet Intern Med 2004, 18:915-917.
116. World Health Organization TNM classification of tumors in domestic animals 1980, WHO, Geneva. L.N. Owen (Ed.).
117. Brooks D, Watson GL Omeprazole in a dog with gastrinoma. J Vet Intern Med 1997, 11:379-381.
118. London CA, Hannah AL, Zadovoskaya R, et al. Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clin Cancer Res 2003, 9:2755-2768.
119. Liao AT, Chien MB, Shenoy N, et al. Inhibition of constitutively active forms of mutant Kit by multitargeted indolinone tyrosine kinase inhibitors. Blood 2002, 100:585-593.
120. Buerger RG, Scott DW Cutaneous mast cell neoplasia in cats: 14 cases (1975-1985). J Am Vet Med Assoc 1987, 190:1440-1444.
121. Chastain CB, Turk MAM, O'Brien D Benign cutaneous mastocytomas in two litters of Siamese kittens. J Am Vet Med Assoc 1988, 193:959-960.
122. Wilcock BP, Yager JA, Zink MC The morphology and behavior of feline cutaneous mastocytomas. Vet Pathol 1986, 23:320-324.
123. Macy DW, Reynolds HA The incidence, characteristics, and clinical management of skin tumors of cats. J Am Anim Hosp Assoc 1981, 17:1026-1034.
124. Neilson SW, Howard EB, Wolke RF Feline mastocytosis. Myeloproliferative disorders of animals and man 1970, US Atomic Energy Commission, Oak Ridge, Tenn, . W.J. Clark, E.B. Howard, P.L. Hackett (Eds.).
125. Spangler WL, Culbertson MR Prevalence and type of splenic diseases in cats: 455 cases (1985-1991). J Am Vet Med Assoc 1992, 201:773-776.
126. Bortnowski HB, Rosenthal RC Gastrointestinal mast cell tumors and eosinophilia in two cats. J Am Anim Hosp Assoc 1992, 28:271-275.
127. Saar C, Opitz M, Lange W, et al. Mastzellenreitkulose bei katzen. Berl Munch Tierarztl Wochenschr 1969, 82:438-444.
128. Mohr FC, Dunston SK Culture and initial characterization of the secretory response of neoplastic cat mast cells. Am J Vet Res 1992, 53:820-828.
129. Feinmehl R, Matus R, Mauldin GN, et al. Splenic mast cell tumors in 43 cats (1975-1992). Proc Annu Conf Vet Cancer Soc 1992, 12:50.
130. Antognoni MT, Spaterna A, Lepri E, et al. Characteristic clinical, haematological and histopathological findings in feline mastocytoma. Vet Res Commun 2003, (27 suppl 1):727-730.
131. Holzinger EA Feline cutaneous mesocytomas. Cornell Vet 1973, 63:87-93.
132. Buss MS, Mollander H, Potter K, et al. Predicting survival and prognosis in cats with cutaneous mastocytomas of varying histological grade. Proc Annu Conf Vet Cancer Soc 1996, 16:56-57.
133. Fondevila D, Rabanal R, Ferrer L Immunoreactivity of canine and feline mast cell tumors. Schweiz Arch Tierheilk 1990, 132:409-484.
134. Johnson TO, Schulman FY, Lipscomb TP, et al. Histopathology and biologic behavior of pleomorphic cutaneous mast cell tumors in fifteen cats. Vet Pathol 2002, 39:452-457.
135. Hanson JA, Papageorges M, Girard E, et al. Ultrasonographic appearance of splenic disease in 101 cats. Vet Radiol Ultrasound 2001, 42:441-445.
136. Sato AF, Solano M Ultrasonographic findings in abdominal mast cell disease: a retrospective study of 19 patients. Vet Radiol Ultrasound 2004, 45:51-57.
137. Schulman A Splenic mastocytosis in a cat. California Vet 1987, 17:17-18.
138. Rassnick KM, Gieger TL, Williams LE, et al. Phase I evaluation of CCNU (lomustine) in tumor-bearing cats. J Vet Intern Med 2001, 15:196-199.
139. Guerre R, Millet P, Groulade P Systemic mastocytosis in a cat: remission after splenectomy. J Small Anim Pract 1979, 20:769-772.
140. Liska WD, MacEwen EG, Zaki FA, et al. Feline systemic mastocytosis: a review and results of splenectomy in seven cases. J Am Anim Hosp Assoc 1979, 15:589-597.
141. Stone RM, Bernstein SH Mast cell leukemia. Cancer medicine 1993, Lea & Febiger, Philadelphia. ed 3. J.F. Holland, E. Frei, R.C. Bast (Eds.).
142. Brockow K Urticaria pigmentosa. Immunol Allergy Clin North Am 2004, 24:287-316.
143. Quaglino PC, Pasquale AD, Colombetti V, et al. Cytobiological and clinical aspects of tissue mast cell leukemia. Br J Haematol 1980, 45:5-12.
144. Casassus P, Caillat-Vigneron N, Martin A, et al. Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients. Br J Haematol 2002, 119:1090-1097.
145. Kluin-Nelemans HC, Oldhoff JM, Van Doormaal JJ, et al. Cladribine therapy for systemic mastocytosis. Blood 2003, 102:4270-4276.
146. Pardanani A, Hoffbrand AV, Butterfield JH, et al. Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine. Leuk Res 2004, 28:127-131.
147. Pardanani A, Elliott M, Reeder T, et al. Imatinib for systemic mast-cell disease. Lancet 2003, 362:535-536.